Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Zhang

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|August 27, 2016
Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) InhibitorSaleem Ahmad, William N Washburn, Andres S Hernandez, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Intraductal Papillary Mucinous Neoplasm Cellular Plasticity is Linked with Repeat Element DysregulationAmaya Pankaj, Michael J Raabe, M Lisa Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2010
Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulationXiang-Yang Ye, Stephanie Chen, Hao Zhang, et al.
Cell Reports|April 28, 2026
GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinomaDennis Gong, Jimmy A Guo, Jennifer Su, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2009
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonistsHao Zhang, Denis E Ryono, Pratik Devasthale, et al.
The Lancet. Neurology|May 17, 2024
Climate change and disorders of the nervous systemSanjay M Sisodiya, Medine I Gulcebi, Francesco Fortunato, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse AgonistsJames J-W Duan, Zhonghui Lu, Bin Jiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with CirrhosisOnofrio Antonio Catalano, Irun Bhan, Luigi Asmundo, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumorsJeanna M Arbesfeld-Qiu, Jae-Won Cho, Phuong T T Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumorsJeanna M Arbesfeld-Qiu, Jae-Won Cho, Phuong T T Nguyen, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|August 27, 2016
Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) InhibitorSaleem Ahmad, William N Washburn, Andres S Hernandez, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Intraductal Papillary Mucinous Neoplasm Cellular Plasticity is Linked with Repeat Element DysregulationAmaya Pankaj, Michael J Raabe, M Lisa Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2010
Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulationXiang-Yang Ye, Stephanie Chen, Hao Zhang, et al.
Cell Reports|April 28, 2026
GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinomaDennis Gong, Jimmy A Guo, Jennifer Su, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2009
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonistsHao Zhang, Denis E Ryono, Pratik Devasthale, et al.
The Lancet. Neurology|May 17, 2024
Climate change and disorders of the nervous systemSanjay M Sisodiya, Medine I Gulcebi, Francesco Fortunato, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse AgonistsJames J-W Duan, Zhonghui Lu, Bin Jiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with CirrhosisOnofrio Antonio Catalano, Irun Bhan, Luigi Asmundo, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumorsJeanna M Arbesfeld-Qiu, Jae-Won Cho, Phuong T T Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumorsJeanna M Arbesfeld-Qiu, Jae-Won Cho, Phuong T T Nguyen, et al.
Pageof 22